Aurora Denver Cardiology Associates

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation4 trials
• Heart failure3 trials
• Familial hypercholesterolaemia2 trials
• Coronary artery disease1 trial
• High blood pressure1 trial
• Pulmonary arterial hypertension1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 41 trial

Status

• Active, not recruiting4 trials
• Completed2 trials
• Recruiting2 trials
• Terminated2 trials

Lead sponsor

• Biosense Webster, Inc.2 trials
• CVRx, Inc.2 trials
• Novartis Pharmaceuticals2 trials
• Impulse Dynamics1 trial
• Janssen Research & Development, LLC1 trial
• and 2 more

Running trials

• Recruiting

  A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

  NCT07527299· Biosense Webster, Inc.· Source

  Contact: Narvelle Delabruere

• Recruiting

  A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

  NCT07227532· Biosense Webster, Inc.· Source

  Contact: Emily Purcell

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

  NCT03970343· Impulse Dynamics· Source

• Active, not recruiting

  ADAPT - A Patient Registry of the Real-world Use of Orenitram®

  NCT03045029· United Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting

Closed trials

• Terminated

  Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence

  NCT05860348· CVRx, Inc.· Source

• Completed

  Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

  NCT04873934· Phase 3· Novartis Pharmaceuticals· Source

• Terminated

  Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

  NCT04502316· CVRx, Inc.· Source

• Completed

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· Phase 4· Population Health Research Institute· Source